SEC probes West Penn Allegheny’s $73 million revenue write-down
The West Penn Allegheny Health System is cooperating with a Securities and Exchange Commission probe of the hospital network's $73 million revenue write-down, said system officials. In a prepared statement, West Penn spokesman Tom Chakurda confirmed the SEC was conducting an "informal inquiry with regard to West Penn Allegheny Health System and the $73 million balance sheet adjustment." West Penn Allegheny refinanced $758 million in bonds last year, but questions arose last month when the president and CEO announced that the health system may have overstated revenue by $73 million, including $67 million in patient receivables.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers